Registration
ARENTFOX SCHIFF LLP for HEMATECH INC
Firm
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medical therapeutic development and appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW JOSEPH KEELEY New | COUNSEL, HOUSE COMMITTEE ON THE JUDICIARY |
| MARGO KLOSTERMAN New | LEGISLATIVE ASST. TO REP. JOHN BOEHNER (R-OH) |
| RACHEL G LATTIMORE New | N/A |
| DAN RENBERG New | N/A |
Medical/Disease Research/Clinical Labs MED
Medical therapeutic development and appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW JOSEPH KEELEY New | COUNSEL, HOUSE COMMITTEE ON THE JUDICIARY |
| MARGO KLOSTERMAN New | LEGISLATIVE ASST. TO REP. JOHN BOEHNER (R-OH) |
| RACHEL G LATTIMORE New | N/A |
| DAN RENBERG New | N/A |
Science/Technology SCI
Medical therapeutic development and appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW JOSEPH KEELEY New | COUNSEL, HOUSE COMMITTEE ON THE JUDICIARY |
| MARGO KLOSTERMAN New | LEGISLATIVE ASST. TO REP. JOHN BOEHNER (R-OH) |
| RACHEL G LATTIMORE New | N/A |
| DAN RENBERG New | N/A |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| KIRIN PHARMA COMPANY, LTD. | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.